Antibody-Drug Conjugate (ADC) Analysis With The Agilent ProteoAnalyzer System
By Whitney Pike
High-resolution CE-SDS analysis offers a clearer window into antibody-drug conjugate (ADC) quality, helping teams confidently assess both size and heterogeneity. Advanced electrophoretic separation enables consistent differentiation of cysteine- and lysine-linked species, supporting precise characterization across complex samples. Quantitative outputs demonstrate strong reproducibility, giving analytical and QC teams a reliable basis for evaluating conjugation patterns and ensuring product consistency. For labs focused on developing or scaling ADCs, these capabilities translate into better insight, improved comparability, and greater confidence in release decisions.
Delve into how refined separation and data accuracy can strengthen your ADC workflows and elevate quality control strategies.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.